Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer

Biochemical and Biophysical Research Communications

Volumn 343, Issue 2, 2006, Pages 571-577

  Gupta, Naren ^a   Martin, Pamela M ^a   Miyauchi, Seiji ^a   Ananth, Sudha ^a   Herdman, Anne V ^a   Martindale, Robert G ^b   Podolsky, Robert ^a   Ganapathy, Vadivel ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

ABCG2 protein; ATP binding cassette transporters; Breast Cancer Resistance Protein; Cervical cancer; Colorectal cancer; Drug resistance and cancer; iNOS; Protoporphyrins

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; COMPLEMENTARY DNA; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLON RESECTION; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MALE; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; ATP-BINDING CASSETTE TRANSPORTERS; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; ORGAN SPECIFICITY; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 33645121623     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.02.172     Document Type: Article

References (19)

1. L.A. Doyle, W. Yang, L.V. Abruzzo, T. Krogmann, Y. Gao, A.K. Rishi, and D.D. Ross A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. USA 95 1998 15665 15670
2. R. Allikmets, L.M. Schriml, A. Hutchinson, V. Romano-Spica, and M. Dean A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance Cancer Res. 58 1998 5337 5339
3. L.A. Doyle, and D.D. Ross Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2) Oncogene 22 2003 7340 7358
4. A. Haimeur, G. Conseil, R.G. Deeley, and S.P. Cole The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation Curr. Drug Metab. 5 2004 21 53
5. M. Maliepaard, G.L. Scheffer, I.F. Faneyte, M.A. van Gastelen, A.C. Pijnenborg, A.H. Schinkel, M.J. van De Vijver, R.J. Scheper, and J.H. Schellens Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues Cancer Res. 61 2001 3458 3464
6. P. Pavek, G. Merino, E. Wagenaar, E. Bolscher, M. Novotna, J.W. Jonker, and A.H. Schinkel Human Breast Cancer Resistance Protein (BCRP/ABCG2): interactions with steroid drugs, hormones, the dietary carcinogen PhIP, and transport of cimetidine J. Pharmacol. Exp. Ther. 312 2005 144 152
7. L.B. Saltz, J.V. Cox, C. Blanke, L.S. Rosen, L. Fehrenbacher, M.J. Moore, J.A. Maroun, S.P. Ackland, P.K. Locker, N. Pirotta, G.L. Elfring, and L.L. Miller Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan study group N. Engl. J. Med. 343 2000 905 914
8. C. Tournigand, T. Andre, E. Achille, G. Lledo, M. Flesh, D. Mery-Mignard, E. Quinaux, C. Couteau, M. Buyse, G. Ganem, B. Landi, P. Colin, C. Louvet, and A. deGramont FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study J. Clin. Oncol. 22 2004 229 237
9. R.J. Mayer Moving beyond fluorouracil for colorectal cancer N. Engl. J. Med. 343 2000 963 964
10. J.W. Jonker, M. Buitelaar, E. Wagenaar, M.A. Van Der Valk, G.L. Scheffer, R.J. Scheper, T. Plosch, F. Kuipers, R.P. Elferink, H. Rosing, J.H. Beijnen, and A.H. Schinkel The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria Proc. Natl. Acad. Sci. USA 99 2002 15649 15654
11. T. Nakamura, H. Fukui, Y. Ishii, K. Ejiri, and M. Ejiri Photodynamic therapy with polypectomy for rectal cancer Gastrointest. Endosc. 57 2003 266 269
12. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 1994 249 258
13. L. Morbidelli, S. Donnini, and M. Ziche Role of nitric oxide in tumor angiogenesis Cancer Treat. Res. 117 2004 155 167
14. 0,+ (SLC6A14) in colorectal cancer and metastasis in humans Biochim. Biophys. Acta 1741 2005 215 223
15. N. Gupta, P.D. Prasad, S. Ghamande, P.M. Martin, A.V. Herdman, R.G. Martindale, R. Podolsky, S. Mager, M.E. Ganapathy, and V. Ganapathy Gynecol. Oncol. 100 2005 8 13
16. A. Jemal, T. Murray, E. Ward, A. Samuels, R.C. Tiwari, A. Ghafoor, E.J. Feuer, and M.J. Thun Cancer statistics, 2005 CA Cancer J. Clin. 55 2005 10 30
17. K. Miyake, L. Mickley, T. Litman, Z. Zhan, R. Robey, B. Cristensen, M. Brangi, L. Greenberger, M. Dean, T. Fojo, and S.E. Bates Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes Cancer Res. 59 1999 8 13
18. K. Yoh, G. Ishii, T. Yokose, Y. Minegishi, K. Tsuta, K. Goto, Y. Nishiwaki, T. Kodama, M. Suga, and A. Ochiai Breast cancer resistance protein impacts clinical outcome in platinum-based chemotherapy for advanced non-small cell lung cancer Clin. Cancer Res. 10 2004 1691 1697
19. M.H. Raaijmakers, E.P. Grouw, L.H. Heuver, B.A. Reijden, J.H. Jansen, G. Scheffer, R.J. Scheper, T.J. Witte, and R.A. Raymakers Impaired breast cancer resistance protein mediated drug transport in plasma cells in multiple myeloma Leuk. Res. 29 2005 1455 1458